# Junta clínica — PT-pseudo_95d3fd02d5e0 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_95d3fd02d5e0",
  "pid": "PT-pseudo_95d3fd02d5e0",
  "task": 1,
  "psa": 5.5,
  "age": 63,
  "months": 3,
  "pirads": "4",
  "psad": 0.11,
  "psav": 0.77,
  "psap": 5.4,
  "vol": 48.0,
  "dre": "Normal",
  "bx": "Positive",
  "cspca": 0.6454933,
  "medhx": "Type 2 diabetes, Coronary artery disease",
  "meds": "metformin, empagliflozin, aspirin 80 mg",
  "notes": "PSA 5.5 ng/mL. PI-RADS 4. PSAD 0.11. Prostate volume 48 mL. csPCa 0.65.",
  "pmhx": [
    "Type 2 diabetes",
    "Coronary artery disease"
  ],
  "allergies": [],
  "vitals": {
    "weight": "88 kg",
    "height": "181 cm",
    "bmi": "26.9",
    "bp": "160/82 mmHg",
    "hr": "66 bpm",
    "smoking": "Non-smoker",
    "last_dental": "2 yr ago",
    "flu_vax": "Nov 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "16 Feb 2025",
  "enc_ref": "Dr. K. Bakker (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Clinical assessment required due to persistently elevated prostate-specific antigen levels and a previous biopsy confirming malignancy."
    },
    {
      "s": "History",
      "t": "A 63-year-old retired bus driver initially entered investigation in mid-2023 after PSA markers began climbing. He abstains from tobacco and alcohol entirely. His medical background includes type 2 diabetes, currently controlled with metformin and empagliflozin, alongside coronary artery disease managed via daily aspirin 80 mg. Severe lower urinary tract symptoms have persisted for years, yielding an IPSS score of 28 out of 35. He covers roughly 20 kilometres on his bicycle twice weekly. Quarterly consultations with a diabetes nurse remain routine, complemented by a recently finished six-session physiotherapy regimen for mechanical lower back pain. Chronic shoulder discomfort is also monitored through a specialized pain clinic. Widowed, he shares a home with his partner and maintains a flexible timetable that easily accommodates his outpatient visits."
    },
    {
      "s": "Physical examination",
      "t": "DRE: Examination reveals a normal prostate profile; the gland is symmetrically enlarged with a smooth, firm consistency and lacks any palpable nodules or asymmetry. Vital parameters remain stable; blood pressure reads 160/82 mmHg while the cardiac rhythm is regular at 66 beats per minute. General observation notes a well-nourished individual free of acute distress, with clear pulmonary fields and consistent heart sounds upon auscultation."
    }
  ],
  "occupation": "retired bus driver",
  "marital": "Widowed",
  "living": "Lives with partner",
  "next_of_kin": "Adult son (primary contact)",
  "recent_other": [
    "Diabetes nurse — quarterly review",
    "Physiotherapy — lower back, six sessions",
    "Pain clinic — chronic shoulder pain"
  ],
  "alcohol": "0 units / week (alcohol-free)",
  "exercise": "Cycling 2x/week, ~20 km",
  "ipss": "IPSS score: 28/35 (severe LUTS)",
  "admin": "Patient self-employed; flexible appointment slots requested.",
  "mri_hospital": "Maastricht UMC+",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_95d3fd02d5e0
Task: 1

Encounter: Urology - outpatient on 16 Feb 2025.
Referrer: Dr. K. Bakker (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 63-year-old male
  - PSA: 5.5 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.11 ng/mL²
  - PSA velocity: 0.77 ng/mL/yr
  - Prior PSA: 5.4 ng/mL
  - Prostate volume: 48.0 mL
  - Months since last PSA: 3
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.6454933 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Type 2 diabetes, Coronary artery disease
  - Problem list / PMHx: Type 2 diabetes, Coronary artery disease
  - Current medication: metformin, empagliflozin, aspirin 80 mg
  - Allergies: NKA
  - Additional notes: PSA 5.5 ng/mL. PI-RADS 4. PSAD 0.11. Prostate volume 48 mL. csPCa 0.65.

Vitals: weight 88 kg, height 181 cm, BMI 26.9, BP 160/82 mmHg, HR 66 bpm. Smoking: Non-smoker.

Chief complaint: Clinical assessment required due to persistently elevated prostate-specific antigen levels and a previous biopsy confirming malignancy.

History: A 63-year-old retired bus driver initially entered investigation in mid-2023 after PSA markers began climbing. He abstains from tobacco and alcohol entirely. His medical background includes type 2 diabetes, currently controlled with metformin and empagliflozin, alongside coronary artery disease managed via daily aspirin 80 mg. Severe lower urinary tract symptoms have persisted for years, yielding an IPSS score of 28 out of 35. He covers roughly 20 kilometres on his bicycle twice weekly. Quarterly consultations with a diabetes nurse remain routine, complemented by a recently finished six-session physiotherapy regimen for mechanical lower back pain. Chronic shoulder discomfort is also monitored through a specialized pain clinic. Widowed, he shares a home with his partner and maintains a flexible timetable that easily accommodates his outpatient visits.

Physical examination: DRE: Examination reveals a normal prostate profile; the gland is symmetrically enlarged with a smooth, firm consistency and lacks any palpable nodules or asymmetry. Vital parameters remain stable; blood pressure reads 160/82 mmHg while the cardiac rhythm is regular at 66 beats per minute. General observation notes a well-nourished individual free of acute distress, with clear pulmonary fields and consistent heart sounds upon auscultation.

Patient info: retired bus driver; Widowed; Lives with partner.
Next of kin: Adult son (primary contact).

Lifestyle: alcohol 0 units / week (alcohol-free); exercise Cycling 2x/week, ~20 km; IPSS score: 28/35 (severe LUTS).

Recent other appointments: Diabetes nurse — quarterly review; Physiotherapy — lower back, six sessions; Pain clinic — chronic shoulder pain.
Admin: Patient self-employed; flexible appointment slots requested.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: NO BIOPSY   p(biopsy) = 0.48
  uncertainty  +/- 0.11 epistemic (95% band 0.27-0.68); among patients I cannot tell apart the outcome was 1.00 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

What moved me most, across the labelled series: prior positive biopsy, PI-RADS >= 4, no prior biopsy, pmhx_hypercholesterolaemia, suspicious DRE, number of comorbidities. I read 39 variables, all
from the panel — nothing from the mpMRI prose, the PSA trajectory, the previous notes or the
laboratory. Out-of-fold over 91 labelled cases: AUC 0.758, balanced
accuracy 0.625.

The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 49 labelled men in this same situation (Positive prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 0.43: PI-RADS 4, PSA 6.5, PSAD 0.11, age 64, DRE Normal -> DEFER (uncertain). He wrote: "Need initial ISUP grade and MRI in men on active surveillance."
  2. distance 0.57: PI-RADS 4, PSA 5.3, PSAD 0.092, age 65, DRE Normal -> BIOPSY (clear). He wrote: "P4 in 65 years old patient"
  3. distance 0.87: PI-RADS 4, PSA 4.7, PSAD 0.07, age 59, DRE Normal -> DEFER (uncertain). He wrote: "PRADS 4 with low-PSA-density can be followed up, I need results of earlier biopsy to make a definite call"

PRECEDENT: DEFER (weighted vote 0.34 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes, laboratory_results.
WHAT HE WEIGHS: bx=important, fh=noted, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted.
HOW SURE HE USUALLY IS: clear.

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The guideline discusses using PI-RADS scores and PSA density to guide the decision to perform a biopsy. It states, "linking PI-RADS score (1-2, 3, and 4-5) to PSA-D categories (< 0.10, 0.10-0.15, 0.15-0.20 and > 0.20ng/mL) (Table 5.5) [230]. This risk-adapted matrix table may guide the decision to perform a biopsy." This requires establishing the patient's PSA density value to determine the appropriate risk stratification.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
Expert-Structured's suggestion of no biopsy is based on a panel of variables that the guideline does not explicitly state are decisive in this specific scenario. The guideline focuses on risk-adapted matrices involving PI-RADS and PSA density, which do not fully account for the prior positive biopsy status as a primary determinant.

WHAT WE STILL NEED
The guideline requires establishing the patient's PSA density value to determine the appropriate risk stratification.
Prior biopsy status: Positive (from panel). The guideline requires knowing the grade of the prior biopsy and the number and dates of biopsy sessions to assess surveillance history.
PSA trend: PSA velocity of 0.77 ng/mL/yr is known, which is a factor in risk assessment.
Laboratory value: PSA density of 0.11 ng/mL² is known, which is required by the guideline for risk stratification.
Laboratory value: The grade of the prior biopsy is not known, which is required by the guideline for assessing surveillance history.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges on establishing the grade of the prior biopsy and the surveillance history documented in the previous notes.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> What is the lesion size and zone of the mpMRI?
  psa_trend (get_psa_trend) -> What is the PSA velocity?
  previous_notes (get_previous_notes) -> What is the Gleason or ISUP grade of the prior biopsy, and what is the surveillance protocol status?
  laboratory_results (get_lab_results) -> What is the PSA density value?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the ISUP grade of the prior biopsy?
  Q2. What is the number and dates of prior biopsy sessions, and is the patient on a surveillance protocol with a confirmatory biopsy due?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
The lesion size and zone of the mpMRI is: "A discrete focus sits in the posterior right mid-gland peripheral zone, spanning 14 x 10 x 12 mm."
psa_trend
The PSA velocity is: "0.77 ng/mL/yr".
previous_notes
The Gleason or ISUP grade of the prior biopsy is: "not recorded", and the surveillance protocol status is: "not recorded".
laboratory_results
The PSA density value is: "0.11 ng/mL/mL".

WHAT I DID NOT OPEN
I did not open the family-history anamnesis because the previous notes provided sufficient context regarding the prior biopsy status and surveillance history.

WHAT THIS SUPPORTS
Findings that argue FOR sampling this patient now:
PI-RADS 4 lesion in the right mid-gland peripheral zone.
PSA velocity of 0.77 ng/mL/yr.

Findings that argue AGAINST sampling this patient now:
Prior positive biopsy status.
Gleason or ISUP grade of the prior biopsy is not recorded.
Surveillance protocol status is not recorded.

WHERE THIS LEANS
The findings suggest that the decision is critically dependent on the missing information regarding the prior biopsy grade and surveillance status, which the EAU guideline explicitly requires.
LEAN: unclear

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 5.50 ng/mL over 5 points spanning 19 months; velocity +2.14 ng/mL per year; doubling time about 14 months.
PROJECTION at 6 months: 7.3 ng/mL, conformal 95% band 2.1-25.4.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report and the laboratory panel; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.64
  uncertainty  +/- 0.08 epistemic (95% band 0.48-0.81), of which 0.00 comes from values that had to be imputed
  reliability  MODERATE ('supports' tier) — out-of-fold it was right 71% of the time over the 24 labelled cases in this tier

What moved me most across the labelled series: prior positive biopsy, no prior biopsy, free PSA < 15%, DWI restriction in the report, lesion >= 15 mm in the report, suspicious DRE. Out-of-fold AUC 0.794. I am the only expert that has read the report's wording, and I still cannot see the prior grade or the
surveillance history: those are in the notes, and the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  DEFER, p(biopsy)=0.48  ('discuss' tier)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.64  ('supports' tier, fusion_full)
  EXPERT-LIBRARY     DEFER, p(biopsy)=0.34  (k=3 precedents)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: weighted vote of the trained experts, p = 0.57 — carried by weighted panel.
PANEL ANSWER: BIOPSY. EXPERT-FUSION carried the most weight ('supports' tier, fusion_full). In this bucket no rule applied and the documents did not record the prior grade, so the trained experts decide.
Dissenting on the board: EXPERT-STRUCTURED, EXPERT-LIBRARY. Their bids are recorded above; they did not carry because a higher rung of the protocol applied.

Confidence the trace model expects here: clear. Weights it expects: bx=important, fh=noted, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents opened by the registrar—radiology_report, psa_trend, previous_notes, and laboratory_results—directly address the moderator's questions by providing the PSA velocity (0.77 ng/mL/yr), the PSA density (0.11 ng/mL/mL), and the lesion size/zone from the MRI. However, the specific information requested regarding the prior biopsy grade (ISUP grade) and the surveillance protocol status remains unrecorded in the retrieved documents.

ALIGNMENT WITH THE PANEL
The retrieved evidence does not directly confirm or refute the PANEL-PROTOCOL's decision of BIOPSY, as the critical missing data points (prior grade and surveillance status) were not retrieved. The panel's decision rests on the trained experts' weighted vote, which was based on the assumption that the documents would provide this context.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the ISUP grade of the prior biopsy? This question remains unanswered, as the previous_notes state the grade is "not recorded."
Q2. What is the number and dates of prior biopsy sessions, and is the patient on a surveillance protocol with a confirmatory biopsy due? This question remains unanswered, as the previous_notes state the surveillance protocol status is "not recorded."

WHAT CARRIES WEIGHT, AND WHY
The two most relevant variables for the EAU guideline are the PSA density (0.11 ng/mL²) and the prior biopsy status. PSA density is required by the guideline for risk stratification, and the prior biopsy status is required to assess surveillance history. These are the key missing pieces that prevent a definitive guideline-based decision.

MY SUGGESTION TO THE CHAIR
The record is not in a state to be decided according to the EAU guideline because the necessary information to apply the risk-adapted matrix is missing. The panel-protocol's answer is not fully supported by the retrieved evidence because the critical variables required by the guideline were not retrieved.

VERDICT: not-ready | SUGGEST: defer | MISSING: previous_notes

[The conference closes after pass 1: every document on the plan is open; nothing outside the plan is ever opened. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

A biopsy is recommended because the fusion classifier suggested it with a probability of 0.64, supported by the presence of a PI-RADS 4 lesion and a rising PSA velocity of 0.77 ng/mL/yr. The decision was settled by the weighted vote of the experts, where the fusion model carried the most weight, despite the missing prior biopsy grade. The evidence converged on the need for further tissue diagnosis given the imaging and PSA trajectory.

What carried weight: bx=important, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Documents this conference opened: radiology_report, psa_trend, previous_notes, laboratory_results
